Patients with common variable immunodeficiency (CVID) display aberrant IL-2 and IFN-gamma mRNA levels.
Hauber
I
I
University of Vienna, Institute of Immunology, Austria.
Fischer
M B
MB
Eibl
M M
MM
D000328:Adult; D017074:Common Variable Immunodeficiency / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D066298:In Vitro Techniques; D007371:Interferon-gamma / Q000235:genetics / Q000378:metabolism*; D007376:Interleukin-2 / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism*; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D013745:Tetanus Toxoid / Q000494:pharmacology
D007376:Interleukin-2; D012333:RNA, Messenger; D011948:Receptors, Antigen, T-Cell; D013745:Tetanus Toxoid; D007371:Interferon-gamma